Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma

World Journal of Gastroenterology

Volumn 21, Issue 3, 2015, Pages 935-943

  Wu, Zhen Feng ^a   Wu, Xiao Yu ^a   Zhu, Nan ^b   Xu, Zhe ^a   Li, Wei Su ^a   Zhang, Hai Bin ^b   Yang, Ning ^b   Yao, Xue Quan ^a   Liu, Fu Kun ^a   Yang, Guang Shun ^b  

^a AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatitis B virus; Intrahepatic cholangiocarcinoma; Lymph node dissection; Lymph node metastases; Postoperative survival

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CHOLECYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEMIHEPATECTOMY; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SPLENECTOMY; SURVIVAL RATE; SURVIVAL TIME; VIRUS CARCINOGENESIS; ADVERSE EFFECTS; BILE DUCT NEOPLASMS; CHI SQUARE DISTRIBUTION; CHOLANGIOCARCINOMA; COMPLICATION; DISEASE COURSE; HEPATITIS B; INTRAHEPATIC BILE DUCT; LIVER RESECTION; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PATIENT SELECTION; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SECONDARY; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; VIROLOGY;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHI-SQUARE DISTRIBUTION; CHOLANGIOCARCINOMA; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HEPATITIS B; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84921519389     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i3.935     Document Type: Article

References (32)

1. Casavilla FA, Marsh JW, Iwatsuki S, Todo S, Lee RG, Madariaga JR, Pinna A, Dvorchik I, Fung JJ, Starzl TE. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 1997; 185: 429-436 [PMID: 9358085 DOI: 10.1016/S1072-7515(01)00953-X].
2. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, Takayasu K, Nakanuma Y, Makuuchi M, Matsuyama Y, Monden M, Kudo M. Report of the 17th Nationwide Followup Survey of Primary Liver Cancer in Japan. Hepatol Res 2007; 37: 676-691 [PMID: 17617112 DOI: 10.1111/j.1872- 034X.2007.00119.x].
3. Aishima S, Kuroda Y, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Am J Surg Pathol 2007; 31: 1059-1067 [PMID: 17592273 DOI: 10.1097/PAS.0b013e31802b34b6].
4. Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, Arase Y, Murashima N, Chayama K, Kumada H. Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000; 88: 2471-2477 [PMID: 10861422].
5. Lee TY, Lee SS, Jung SW, Jeon SH, Yun SC, Oh HC, Kwon S, Lee SK, Seo DW, Kim MH, Suh DJ. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: A case-control study. Am J Gastroenterol 2008; 103: 1716-1720 [PMID: 18557716 DOI: 10.1111/j.1572-0241.2008.01796.x].
6. Hai S, Kubo S, Yamamoto S, Uenishi T, Tanaka H, Shuto T, Takemura S, Yamazaki O, Hirohashi K. Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma. Dig Surg 2005; 22: 432-439 [PMID: 16479112 DOI: 10.1159/000091446].
7. Lee CH, Chang CJ, Lin YJ, Yeh CN, Chen MF, Hsieh SY. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer 2009; 100: 1765-1770 [PMID: 19436294 DOI: 10.1038/sj.bjc.6605063].
8. Zhou H, Wang H, Zhou D, Wang H, Wang Q, Zou S, Tu Q, Wu M, Hu H. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis. Eur J Cancer 2010; 46: 1056-1061 [PMID: 20202823 DOI: 10.1016/j.ejca.2010.02.005].
9. Bhagat V, Javle M, Yu J, Agrawal A, Gibbs JF, Kuvshinoff B, Nava E, Iyer R. Combined hepatocholangiocarcinoma: caseseries and review of literature. Int J Gastrointest Cancer 2006; 37: 27-34 [PMID: 17290078].
10. Koh KC, Lee H, Choi MS, Lee JH, Paik SW, Yoo BC, Rhee JC, Cho JW, Park CK, Kim HJ. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 2005; 189: 120-125 [PMID: 15701504 DOI: 10.1016/j.amjsurg.2004.03.018].
11. Zhang F, Chen XP, Zhang W, Dong HH, Xiang S, Zhang WG, Zhang BX. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: Immunohistochemical and double-fluorescence immunostaining evidence. Histopathology 2008; 52: 224-232 [PMID: 18184271 DOI: 10.1111/j.1365-2559.2007.02929.x].
12. Peng NF, Li LQ, Qin X, Guo Y, Peng T, Xiao KY, Chen XG, Yang YF, Su ZX, Chen B, Su M, Qi LN. Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: A possible role of hepatitis B virus. Ann Surg Oncol 2011; 18: 1258-1266 [PMID: 21207172 DOI: 10.1245/s10434-010-1458-5].
13. Wu ZF, Yang N, Li DY, Zhang HB, Yang GS. Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumours. J Viral Hepat 2013; 20: 306-310 [PMID: 23565611 DOI: 10.1111/jvh.12005].
14. Zhou HB, Wang H, Li YQ, Li SX, Wang H, Zhou DX, Tu QQ, Wang Q, Zou SS, Wu MC, Hu HP. Hepatitis B virus infection: A favorable prognostic factor for intrahepatic cholangiocarcinoma after resection. World J Gastroenterol 2011; 17: 1292-1303 [PMID: 21455328 DOI: 10.3748/wjg.v17. i10.1292].
15. Zhou XD, Tang ZY, Fan J, Zhou J, Wu ZQ, Qin LX, Ma ZC, Sun HC, Qiu SJ, Yu Y, Ren N, Ye QH, Wang L, Ye SL. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5, 829 patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 2009; 135: 1073-1080 [PMID: 19294418 DOI: 10.1007/s00432-009-0547-y].
16. Tang D, Nagano H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Monden M. Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: A comparative study with hepatocellular carcinoma and cholangiocellular carcinoma. J Gastrointest Surg 2006; 10: 987-998 [PMID: 16843869 DOI: 10.1016/j.gassur.2006.01.018].
17. Shimada M, Yamashita Y, Aishima S, Shirabe K, Takenaka K, Sugimachi K. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 2001; 88: 1463-1466 [PMID: 11683741 DOI: 10.1046/j.0007-1323.2001.01879.x].
18. Yamamoto M, Takasaki K, Yoshikawa T. Lymph node metastasis in intrahepatic cholangiocarcinoma. Jpn J Clin Oncol 1999; 29: 147-150 [PMID: 10225697 DOI: 10.1093/jjco/29.3.147].
19. Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Hamba H, Tanaka H, Kinoshita H. Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma. World J Surg 2001; 25: 865-869 [PMID: 11572025 DOI: 10.1007/s00268-001-0042-3].
20. Vitale F, Tramuto F, Orlando A, Vizzini G, Meli V, Cerame G, Mazzucco W, Virdone R, Palazzo U, Villafrate MR, Tagger A, Romano N. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection? J Med Virol 2008; 80: 577-582 [PMID: 18297707 DOI: 10.1002/jmv.21121].
21. Shiota G, Oyama K, Udagawa A, Tanaka K, Nomi T, Kitamura A, Tsutsumi A, Noguchi N, Takano Y, Yashima K, Kishimoto Y, Suou T, Kawasaki H. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: Involvement of HBx and p53. J Med Virol 2000; 62: 151-158 [PMID: 11002243].
22. Yang T, Zhang J, Lu JH, Yang LQ, Yang GS, Wu MC, Yu WF. A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort. J Cancer Res Clin Oncol 2011; 137: 739-750 [PMID: 20607551 DOI: 10.1007/s00432-010-0935-3].
23. Wu ZF, Zhang HB, Yang N, Zhao WC, Fu Y, Yang GS. Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: results of a large monocentric series. Eur J Surg Oncol 2012; 38: 602-610 [PMID: 22417704 DOI: 10.1016/j.ejso.2012.02.185].
24. Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ, Chung JB. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: Association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 2009; 16: 3048-3056 [PMID: 19626372 DOI: 10.1245/s10434-009-0631-1].
25. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, Miyazaki M. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002; 89: 1525-1531 [PMID: 12445060 DOI: 10.1046/j.1365-2168.2002.02268.x].
26. Nakagawa T, Kamiyama T, Kurauchi N, Matsushita M, Nakanishi K, Kamachi H, Kudo T, Todo S. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 2005; 29: 728-733 [PMID: 15880276 DOI: 10.1007/s00268-005-7761-9].
27. Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases. J Surg Oncol 2007; 96: 160-165 [PMID: 17443744 DOI: 10.1002/jso.20792].
28. Nakagohri T, Asano T, Kinoshita H, Kenmochi T, Urashima T, Miura F, Ochiai T. Aggressive surgical resection for hilarinvasive and peripheral intrahepatic cholangiocarcinoma. World J Surg 2003; 27: 289-293 [PMID: 12607053 DOI: 10.1007/s00268-002-6696-7].
29. Weber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y, Blumgart LH. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 2001; 193: 384-391 [PMID: 11584966 DOI: 10.1016/S1072- 7515(01)01016-X].
30. Tajima Y, Kuroki T, Fukuda K, Tsuneoka N, Furui J, Kanematsu T. An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma. Br J Surg 2004; 91: 99-104 [PMID: 14716802 DOI: 10.1002/bjs.4366].
31. Asakura H, Ohtsuka M, Ito H, Kimura F, Ambiru S, Shimizu H, Togawa A, Yoshidome H, Kato A, Miyazaki M. Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis. Hepatogastroenterology 2005; 52: 722-724 [PMID: 15966191].
32. Uenishi T, Yamazaki O, Horii K, Yamamoto T, Kubo S. A long-term survivor of intrahepatic cholangiocarcinoma with paraaortic lymph node metastasis. J Gastroenterol 2006; 41: 391-392 [PMID: 16741622 DOI: 10.1007/s00535-006-1757-6].